ABT-414 in patients with advanced solid tumors likely to overexpress the epidermal growth factor receptor (EGFR).
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Glenwood D. Goss, Everett E. Vokes, Michael S. Gordon, Leena Gandhi, Kyriakos P. Papadopoulos, Drew Warren Rasco, Michelle Pedersen, Judee S. Fischer, Katharine Chu, William Ames, Hao Xiong, Ho-Jin Lee, Jiewei Zeng, Lisa Roberts-Rapp, Peter Ansell, Ed Reilly, Kyle D. Holen, Anthony W. Tolcher
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2600769610
